Johan M. Kros

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text

Medicine, Molecular Biology, Oncology +17

Intertumoral Heterogeneity within Medulloblastoma Subgroups

Florence M.G. Cavalli, Marc Remke, Ladislav Rampášek et al. · Cancer Cell · 2017 · 1.3K citations · Full text

Medicine, Genetics, Oncology +14

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Paul A. Northcott, David Shih, John Peacock et al. · Nature · 2012 · 921 citations · Full text

Medicine, Genetics, Oncology +17

Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology

Lonneke A.M. Gravendeel, Mathilde C.M. Kouwenhoven, Olivier Gevaert et al. · Cancer Research · 2009 · 708 citations

Medicine, Molecular Biology, Oncology +16